Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI review

J Neurol. 2023 Apr;270(4):1880-1907. doi: 10.1007/s00415-022-11518-9. Epub 2022 Dec 13.

Abstract

This review aims to define awareness impairment and related disturbances in neurodegenerative diseases, including Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) spectrum of disorders. An update of the available scientific literature on the use of magnetic resonance imaging (MRI) in the study of awareness in these disorders is also offered. MRI plays an important role in the characterization of neurodegenerative signatures and can increase our knowledge on brain structural and functional correlates of awareness. In the reviewing process, we established a-priori criteria and we searched the scientific literature for relevant articles on this topic. In summary, we selected 36 articles out of 1340 publications retrieved from PubMed. Based on this selection, this review discusses the multiple terms used to define different or overlapping aspects of awareness impairment, and specifically summarizes recent application of MRI for investigating anosognosia, social cognition, including theory of mind and emotional processing, free will, and autonoetic awareness alterations in different neurodegenerative disorders, with most of these studies focused on AD and FTLD. This systematic review highlights the importance of awareness impairment and related domains in neurodegenerative disorders, especially in AD and FTLD, and it outlines MRI structural and functional correlates in these populations.

Keywords: Alzheimer’s disease; Awareness; Frontotemporal dementia; Magnetic resonance imaging; Neurodegenerative disorders; Systematic review.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Alzheimer Disease*
  • Frontotemporal Dementia* / psychology
  • Frontotemporal Lobar Degeneration* / diagnostic imaging
  • Frontotemporal Lobar Degeneration* / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Neurodegenerative Diseases*